There is limited data about the use of GLP-1 RA in post-bariatric WR or IWL, which were found to be more effective for treating post-bariatric weight regain than non-GLP-1 RAbased pharmacotherapies regardless of surgery type [21]
While our treatments are powerful on their own, combining them with a balanced diet and regular exercise will maximize your results
You ate when you were hungry, and stopped when you were full
Studies also show a 32% adverse event rate, including liver dysfunction
So, our focus on risk reduction for people with diabetes and CKD must be holistic and focus not only on risk of kidney failure, but on cardiovascular outcomes and mortality. The double-blind, randomized, placebo-controlled international trial enrolled 3,533 participants with a median follow-up period of 3.4 years